Literature DB >> 14991529

Accuracy and precision in HER2/neu testing in breast cancer: are we there yet?

Hadi Yaziji, Allen M Gown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14991529     DOI： 10.1016/j.humpath.2004.01.002

Source DB:  PubMed          Journal:  Hum Pathol        ISSN： 0046-8177            Impact factor:   3.466


× No keyword cloud information.
  11 in total

1.  Use of tissue microarray for interlaboratory validation of HER2 immunocytochemical and FISH testing.

Authors:  E Kay; A O'Grady; J M Morgan; S Wozniak; B Jasani
Journal:  J Clin Pathol       Date:  2004-11       Impact factor: 3.411

2.  [Molecular protocol for HER2/neu analysis in breast carcinoma].

Authors:  Montse Verdú Artufel; Anna Colomer Valero; Ruth Román Lladó; Nadina Erill Sagalés; Miquel Calvo Llorca; Abelardo Moreno Carazo; Carlos Cordón Cardó; Xavier Puig Torrus
Journal:  Clin Transl Oncol       Date:  2005-12       Impact factor: 3.405

3.  Correlation of HER2 overexpression with gene amplification and its relation to chromosome 17 aneuploidy: a 5-year experience with invasive ductal and lobular carcinomas.

Authors:  Aziza Nassar; Andras Khoor; Reshmitha Radhakrishnan; Anu Radhakrishnan; Cynthia Cohen
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  Resistance to HER2-targeted therapies: a potential role for FOXM1.

Authors:  Bridgette F Peake; Rita Nahta
Journal:  Breast Cancer Manag       Date:  2014

5.  Overexpression/amplification of HER-2/neu is uncommon in hepatocellular carcinoma.

Authors:  Z-H Xian; S-H Zhang; W-M Cong; W-Q Wu; M-C Wu
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

6.  Computer-aided scoring of erb-b2 receptor tyrosine kinase 2 (HER2) gene amplification status in breast cancer.

Authors:  Alyson Yoder; Landon J Inge; Chen-Chun Chen; Vijay R Marati; Trung Kien Nguyen; Karel Zuiderveld; Jim Martin; Sarah Gladden; Mohammad Saleh Miri; Raghavan Venugopal; Bryan Lopez; Jim Ranger-Moore; Christoph Guetter
Journal:  J Pathol Inform       Date:  2022-07-05

7.  Immunohistochemical detection of estrogen and progesterone receptor and HER2 expression in breast carcinomas: comparison of cell block and tissue block preparations.

Authors:  Sharenda L Williams; George G Birdsong; Cynthia Cohen; Momin T Siddiqui
Journal:  Int J Clin Exp Pathol       Date:  2009-01-20

8.  Automated quantitative assessment of HER-2/neu immunohistochemical expression in breast cancer.

Authors:  Hela Masmoudi; Stephen M Hewitt; Nicholas Petrick; Kyle J Myers; Marios A Gavrielides
Journal:  IEEE Trans Med Imaging       Date:  2009-01-19       Impact factor: 10.048

9.  High-density SNP arrays improve detection of HER2 amplification and polyploidy in breast tumors.

Authors:  Thomas V O Hansen; Jonas Vikesaa; Sine S Buhl; Henrik H Rossing; Vera Timmermans-Wielenga; Finn C Nielsen
Journal:  BMC Cancer       Date:  2015-02-06       Impact factor: 4.430

10.  ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of driver-negative melanoma.

Authors:  Katherine E Hutchinson; Douglas B Johnson; Adam S Johnson; Violeta Sanchez; Maria Kuba; Pengcheng Lu; Xi Chen; Mark C Kelley; Qingguo Wang; Zhongming Zhao; Mark Kris; Michael F Berger; Jeffrey A Sosman; William Pao
Journal:  Oncotarget       Date:  2015-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.